Feb. 26, 2026—ARUP Laboratories has launched the Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. ARUP says the new laboratory will serve as an ecosystem for validating technologies and accelerating next-generation diagnostics from concept to commercialization.
“The Innovation Central Laboratory represents a bold step forward in diagnostic medicine,” Tracy George, MD, ARUP chief scientific officer and president of ARUP’s Innovation Business Unit, said in a press statement. “By building and validating tests that are truly commercial-ready, we’re not just accelerating innovation, we’re ensuring that groundbreaking diagnostics can be adopted in real-world laboratories to improve patient care globally.”
Other initiatives of the Innovation Central Laboratory include developing assays for rare and under-recognized diseases, improving genomic sequencing technologies, operationalizing artificial intelligence and digital pathology solutions into laboratory workflows, and facilitating biomarker discovery and development of new assays for neurodegenerative diseases.